SecFilingDex

Arcellx, Inc.

43 SEC EDGAR filings indexed (CIK 0001786205) across 13 form types.

Filing profile

Arcellx, Inc. (ACLX) has 43 SEC filings indexed on SecFilingDex, across 13 form types filed over roughly 2 years, from April 10, 2024 to April 30, 2026. The filer is classified under Biological Products (SIC 2836).

Its most frequent disclosure is the 8-K (Material event) with 8 filings — Current report announcing a material event, such as an acquisition, executive change, or earnings release. 22 of these filings were disclosed in the twelve months to April 30, 2026. 11 of the 43 are amendments (a corrected or updated version of an earlier filing).

Disclosure mix

  • 88-KMaterial event · event-driven
  • 8Form 4Insider transaction · within 2 business days of transaction
  • 610-QQuarterly report · quarterly
  • 6SC 13G/A5%+ passive stake · event-driven
  • 3Form 4/AInsider transaction · within 2 business days of transaction
  • 210-KAnnual report · annual
  • 2DEF 14AProxy statement · annual (pre-meeting)
  • 2DEFA14ASEC filing
  • 2Form 3Initial insider ownership · within 10 days of becoming an insider
  • 1SC 13D/A5%+ activist stake · event-driven (within 10 days)
  • 110-K/AAnnual report · annual
  • 1SC 13G5%+ passive stake · event-driven
  • 1SC 13D5%+ activist stake · event-driven (within 10 days)

Profile derived from 43 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1786205&type=&dateb=&owner=include&count=40

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.